Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; Department of Renal Medicine, Counties Manukau District Health Board, Auckland, New Zealand; Therapeutic Area, Baxter Healthcare (Asia) Pte. Ltd., Singapore.
Kidney Int. 2016 Nov;90(5):936-938. doi: 10.1016/j.kint.2016.06.040. Epub 2016 Sep 16.
Incremental hemodialysis may offer substantial clinical, patient-centered, and cost benefits. In the largest and most rigorous study to date, Mathew et al. show that incremental hemodialysis is associated with satisfactory survival in those with adequate residual renal function and reasonable general health. While encouraging, these findings are a call to action for a suitably powered randomized clinical trial, to generate definitive evidence of benefit with this approach and define optimal practice for "real-world" implementation.
递增式血液透析可能具有显著的临床、以患者为中心和成本效益。在迄今为止最大和最严格的研究中,Mathew 等人表明,对于那些有足够残余肾功能和合理一般健康状况的患者,递增式血液透析与令人满意的生存相关。虽然这些发现令人鼓舞,但它们呼吁进行一项适当规模的随机临床试验,以产生这种方法具有益处的确凿证据,并为“真实世界”实施定义最佳实践。